In July 2026, Bill Ackman, a billionaire investor, finalized the purchase of two buildings on the Upper West Side of Manhattan for $260 million. This acquisition is intended for the establishment of the Ackman Oxman Institute, a facility dedicated to comprehensive brain research. The institute aims to bring together experts in various fields, including genetics, nutrition, and neurosurgery, to advance understanding and treatment of brain-related issues. The initiative is particularly personal for Ackman, as it stems from his daughter's health challenges and the loss of his wife Neri Oxman's mother to Alzheimer's disease five years prior.
The new center will be built on the site currently housing West End Labs, a life sciences and research campus. Ackman envisions the institute as a hub for innovative research and treatment, leveraging insights gained from his daughter's experimental treatments. The facility is expected to include state-of-the-art resources for neurosurgery and other brain-related studies, potentially surpassing existing research institutions in New York City.
Funding for the Ackman Oxman Institute will be provided by Pershing Square Philanthropies, which has already invested over a billion dollars in various philanthropic efforts. The institute's board will include notable figures such as Nobel Prize winner Jim Rothman and Stanford neuroscientist Andrew Huberman. They are currently in the process of hiring the institute's first CEO and expect operations to commence by the end of the year.
Ackman's commitment to this project reflects his broader philanthropic interests and his personal experiences with brain health. He has been an outspoken advocate for various causes, using his platform to influence public opinion and policy. The establishment of the Ackman Oxman Institute represents a significant step in his career, aiming to make a lasting impact on brain research and treatment methodologies.
